NGS-based RNA-seq Market - Global Outlook and Forecast 2022-2028

January 2022 | 71 pages | ID: NCD3F22ABD1CEN
Market Monitor Global

Abstracts

Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.

This report contains market size and forecasts of NGS-based RNA-seq in Global, including the following market information:

Global NGS-based RNA-seq Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global NGS-based RNA-seq market was valued at 1578.9 million in 2021 and is projected to reach US$ 3239.7 million by 2028, at a CAGR of 10.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

High-Throughput Sequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of NGS-based RNA-seq include Illumina, Thermo Fisher Scientific, Pacific Biosciences Of California, Qaigen, F. Hoffmann-La Roche, Agilent Technologies, Oxford Nanopore Technologies, Perkinelmer and Eurofins Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NGS-based RNA-seq companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global NGS-based RNA-seq Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global NGS-based RNA-seq Market Segment Percentages, by Type, 2021 (%)

• High-Throughput Sequencing
• Third-Generation Sequencing Technology

Global NGS-based RNA-seq Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global NGS-based RNA-seq Market Segment Percentages, by Application, 2021 (%)

• Hospitals and Clinics
• Biopharma Companies
• Government Agencies
• Academic and Research Organizations
• Other

Global NGS-based RNA-seq Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global NGS-based RNA-seq Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies NGS-based RNA-seq revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies NGS-based RNA-seq revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Illumina
• Thermo Fisher Scientific
• Pacific Biosciences Of California
• Qaigen
• F. Hoffmann-La Roche
• Agilent Technologies
• Oxford Nanopore Technologies
• Perkinelmer
• Eurofins Scientific
• Gatc Biotech
• Macrogen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 NGS-based RNA-seq Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global NGS-based RNA-seq Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NGS-BASED RNA-SEQ OVERALL MARKET SIZE

2.1 Global NGS-based RNA-seq Market Size: 2021 VS 2028
2.2 Global NGS-based RNA-seq Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top NGS-based RNA-seq Players in Global Market
3.2 Top Global NGS-based RNA-seq Companies Ranked by Revenue
3.3 Global NGS-based RNA-seq Revenue by Companies
3.4 Top 3 and Top 5 NGS-based RNA-seq Companies in Global Market, by Revenue in 2021
3.5 Global Companies NGS-based RNA-seq Product Type
3.6 Tier 1, Tier 2 and Tier 3 NGS-based RNA-seq Players in Global Market
  3.6.1 List of Global Tier 1 NGS-based RNA-seq Companies
  3.6.2 List of Global Tier 2 and Tier 3 NGS-based RNA-seq Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global NGS-based RNA-seq Market Size Markets, 2021 & 2028
  4.1.2 High-Throughput Sequencing
  4.1.3 Third-Generation Sequencing Technology
4.2 By Type - Global NGS-based RNA-seq Revenue & Forecasts
  4.2.1 By Type - Global NGS-based RNA-seq Revenue, 2017-2022
  4.2.2 By Type - Global NGS-based RNA-seq Revenue, 2023-2028
  4.2.3 By Type - Global NGS-based RNA-seq Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global NGS-based RNA-seq Market Size, 2021 & 2028
  5.1.2 Hospitals and Clinics
  5.1.3 Biopharma Companies
  5.1.4 Government Agencies
  5.1.5 Academic and Research Organizations
  5.1.6 Other
5.2 By Application - Global NGS-based RNA-seq Revenue & Forecasts
  5.2.1 By Application - Global NGS-based RNA-seq Revenue, 2017-2022
  5.2.2 By Application - Global NGS-based RNA-seq Revenue, 2023-2028
  5.2.3 By Application - Global NGS-based RNA-seq Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global NGS-based RNA-seq Market Size, 2021 & 2028
6.2 By Region - Global NGS-based RNA-seq Revenue & Forecasts
  6.2.1 By Region - Global NGS-based RNA-seq Revenue, 2017-2022
  6.2.2 By Region - Global NGS-based RNA-seq Revenue, 2023-2028
  6.2.3 By Region - Global NGS-based RNA-seq Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America NGS-based RNA-seq Revenue, 2017-2028
  6.3.2 US NGS-based RNA-seq Market Size, 2017-2028
  6.3.3 Canada NGS-based RNA-seq Market Size, 2017-2028
  6.3.4 Mexico NGS-based RNA-seq Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe NGS-based RNA-seq Revenue, 2017-2028
  6.4.2 Germany NGS-based RNA-seq Market Size, 2017-2028
  6.4.3 France NGS-based RNA-seq Market Size, 2017-2028
  6.4.4 U.K. NGS-based RNA-seq Market Size, 2017-2028
  6.4.5 Italy NGS-based RNA-seq Market Size, 2017-2028
  6.4.6 Russia NGS-based RNA-seq Market Size, 2017-2028
  6.4.7 Nordic Countries NGS-based RNA-seq Market Size, 2017-2028
  6.4.8 Benelux NGS-based RNA-seq Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia NGS-based RNA-seq Revenue, 2017-2028
  6.5.2 China NGS-based RNA-seq Market Size, 2017-2028
  6.5.3 Japan NGS-based RNA-seq Market Size, 2017-2028
  6.5.4 South Korea NGS-based RNA-seq Market Size, 2017-2028
  6.5.5 Southeast Asia NGS-based RNA-seq Market Size, 2017-2028
  6.5.6 India NGS-based RNA-seq Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America NGS-based RNA-seq Revenue, 2017-2028
  6.6.2 Brazil NGS-based RNA-seq Market Size, 2017-2028
  6.6.3 Argentina NGS-based RNA-seq Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa NGS-based RNA-seq Revenue, 2017-2028
  6.7.2 Turkey NGS-based RNA-seq Market Size, 2017-2028
  6.7.3 Israel NGS-based RNA-seq Market Size, 2017-2028
  6.7.4 Saudi Arabia NGS-based RNA-seq Market Size, 2017-2028
  6.7.5 UAE NGS-based RNA-seq Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Illumina
  7.1.1 Illumina Corporate Summary
  7.1.2 Illumina Business Overview
  7.1.3 Illumina NGS-based RNA-seq Major Product Offerings
  7.1.4 Illumina NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.1.5 Illumina Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific NGS-based RNA-seq Major Product Offerings
  7.2.4 Thermo Fisher Scientific NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fisher Scientific Key News
7.3 Pacific Biosciences Of California
  7.3.1 Pacific Biosciences Of California Corporate Summary
  7.3.2 Pacific Biosciences Of California Business Overview
  7.3.3 Pacific Biosciences Of California NGS-based RNA-seq Major Product Offerings
  7.3.4 Pacific Biosciences Of California NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.3.5 Pacific Biosciences Of California Key News
7.4 Qaigen
  7.4.1 Qaigen Corporate Summary
  7.4.2 Qaigen Business Overview
  7.4.3 Qaigen NGS-based RNA-seq Major Product Offerings
  7.4.4 Qaigen NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.4.5 Qaigen Key News
7.5 F. Hoffmann-La Roche
  7.5.1 F. Hoffmann-La Roche Corporate Summary
  7.5.2 F. Hoffmann-La Roche Business Overview
  7.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Major Product Offerings
  7.5.4 F. Hoffmann-La Roche NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.5.5 F. Hoffmann-La Roche Key News
7.6 Agilent Technologies
  7.6.1 Agilent Technologies Corporate Summary
  7.6.2 Agilent Technologies Business Overview
  7.6.3 Agilent Technologies NGS-based RNA-seq Major Product Offerings
  7.6.4 Agilent Technologies NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.6.5 Agilent Technologies Key News
7.7 Oxford Nanopore Technologies
  7.7.1 Oxford Nanopore Technologies Corporate Summary
  7.7.2 Oxford Nanopore Technologies Business Overview
  7.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Major Product Offerings
  7.7.4 Oxford Nanopore Technologies NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.7.5 Oxford Nanopore Technologies Key News
7.8 Perkinelmer
  7.8.1 Perkinelmer Corporate Summary
  7.8.2 Perkinelmer Business Overview
  7.8.3 Perkinelmer NGS-based RNA-seq Major Product Offerings
  7.8.4 Perkinelmer NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.8.5 Perkinelmer Key News
7.9 Eurofins Scientific
  7.9.1 Eurofins Scientific Corporate Summary
  7.9.2 Eurofins Scientific Business Overview
  7.9.3 Eurofins Scientific NGS-based RNA-seq Major Product Offerings
  7.9.4 Eurofins Scientific NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.9.5 Eurofins Scientific Key News
7.10 Gatc Biotech
  7.10.1 Gatc Biotech Corporate Summary
  7.10.2 Gatc Biotech Business Overview
  7.10.3 Gatc Biotech NGS-based RNA-seq Major Product Offerings
  7.10.4 Gatc Biotech NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.10.5 Gatc Biotech Key News
7.11 Macrogen
  7.11.1 Macrogen Corporate Summary
  7.11.2 Macrogen Business Overview
  7.11.3 Macrogen NGS-based RNA-seq Major Product Offerings
  7.11.4 Macrogen NGS-based RNA-seq Revenue in Global Market (2017-2022)
  7.11.5 Macrogen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. NGS-based RNA-seq Market Opportunities & Trends in Global Market
Table 2. NGS-based RNA-seq Market Drivers in Global Market
Table 3. NGS-based RNA-seq Market Restraints in Global Market
Table 4. Key Players of NGS-based RNA-seq in Global Market
Table 5. Top NGS-based RNA-seq Players in Global Market, Ranking by Revenue (2021)
Table 6. Global NGS-based RNA-seq Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global NGS-based RNA-seq Revenue Share by Companies, 2017-2022
Table 8. Global Companies NGS-based RNA-seq Product Type
Table 9. List of Global Tier 1 NGS-based RNA-seq Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NGS-based RNA-seq Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global NGS-based RNA-seq Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - NGS-based RNA-seq Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - NGS-based RNA-seq Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global NGS-based RNA-seq Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - NGS-based RNA-seq Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - NGS-based RNA-seq Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global NGS-based RNA-seq Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global NGS-based RNA-seq Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global NGS-based RNA-seq Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America NGS-based RNA-seq Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America NGS-based RNA-seq Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe NGS-based RNA-seq Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe NGS-based RNA-seq Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia NGS-based RNA-seq Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia NGS-based RNA-seq Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America NGS-based RNA-seq Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America NGS-based RNA-seq Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa NGS-based RNA-seq Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa NGS-based RNA-seq Revenue, (US$, Mn), 2023-2028
Table 30. Illumina Corporate Summary
Table 31. Illumina NGS-based RNA-seq Product Offerings
Table 32. Illumina NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific NGS-based RNA-seq Product Offerings
Table 35. Thermo Fisher Scientific NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 36. Pacific Biosciences Of California Corporate Summary
Table 37. Pacific Biosciences Of California NGS-based RNA-seq Product Offerings
Table 38. Pacific Biosciences Of California NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 39. Qaigen Corporate Summary
Table 40. Qaigen NGS-based RNA-seq Product Offerings
Table 41. Qaigen NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann-La Roche Corporate Summary
Table 43. F. Hoffmann-La Roche NGS-based RNA-seq Product Offerings
Table 44. F. Hoffmann-La Roche NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 45. Agilent Technologies Corporate Summary
Table 46. Agilent Technologies NGS-based RNA-seq Product Offerings
Table 47. Agilent Technologies NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 48. Oxford Nanopore Technologies Corporate Summary
Table 49. Oxford Nanopore Technologies NGS-based RNA-seq Product Offerings
Table 50. Oxford Nanopore Technologies NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 51. Perkinelmer Corporate Summary
Table 52. Perkinelmer NGS-based RNA-seq Product Offerings
Table 53. Perkinelmer NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 54. Eurofins Scientific Corporate Summary
Table 55. Eurofins Scientific NGS-based RNA-seq Product Offerings
Table 56. Eurofins Scientific NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 57. Gatc Biotech Corporate Summary
Table 58. Gatc Biotech NGS-based RNA-seq Product Offerings
Table 59. Gatc Biotech NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)
Table 60. Macrogen Corporate Summary
Table 61. Macrogen NGS-based RNA-seq Product Offerings
Table 62. Macrogen NGS-based RNA-seq Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. NGS-based RNA-seq Segment by Type in 2021
Figure 2. NGS-based RNA-seq Segment by Application in 2021
Figure 3. Global NGS-based RNA-seq Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global NGS-based RNA-seq Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global NGS-based RNA-seq Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by NGS-based RNA-seq Revenue in 2021
Figure 8. By Type - Global NGS-based RNA-seq Revenue Market Share, 2017-2028
Figure 9. By Application - Global NGS-based RNA-seq Revenue Market Share, 2017-2028
Figure 10. By Region - Global NGS-based RNA-seq Revenue Market Share, 2017-2028
Figure 11. By Country - North America NGS-based RNA-seq Revenue Market Share, 2017-2028
Figure 12. US NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 13. Canada NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe NGS-based RNA-seq Revenue Market Share, 2017-2028
Figure 16. Germany NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 17. France NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 19. Italy NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 20. Russia NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia NGS-based RNA-seq Revenue Market Share, 2017-2028
Figure 24. China NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 25. Japan NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 28. India NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America NGS-based RNA-seq Revenue Market Share, 2017-2028
Figure 30. Brazil NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa NGS-based RNA-seq Revenue Market Share, 2017-2028
Figure 33. Turkey NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 34. Israel NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 36. UAE NGS-based RNA-seq Revenue, (US$, Mn), 2017-2028
Figure 37. Illumina NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fisher Scientific NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pacific Biosciences Of California NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Qaigen NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann-La Roche NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Agilent Technologies NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Oxford Nanopore Technologies NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Perkinelmer NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Eurofins Scientific NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Gatc Biotech NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Macrogen NGS-based RNA-seq Revenue Year Over Year Growth (US$, Mn) & (2017-2022)